Call For Targets
Translating your portfolio of small molecule and antibody targets
Our partners
Technology transfer services
We provide our expertise in technology transfer and intellectual property management to academic, charitable and other not-for-profit organisations.
Currently, we work with:
UK Medical Research Council: a publicly-funded organisation dedicated to improving human health. The MRC supports research across the entire spectrum of medical sciences, in universities and hospitals, in its own units, centres and institutes in the UK, and in its units in Africa.
The Association of International Cancer Research: a charity that funds cutting edge research into the causes of cancer. all over the world.
News feed
MRCT have recently launched a second collaboration with the University of Bristol in the area of pain medicine.
Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis
Researchers at the Breakthrough Breast Cancer Research Unit have used OPT imaging to measure changes in tumour volume.
Barbara Saxty has co-authored a Nature Communications paper entitled An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.



